0 likes | 8 Views
The formulation used during drug development phase 1 plays a critical role in determining how the drug behaves in the human body and how it interacts with various biological systems. Proper formulation is necessary for both safety and effectiveness, setting the stage for later clinical phases. This article explores the challenges and considerations involved in developing formulations for Phase 1 clinical trials, and how advancements in clinical trial data solutions are streamlining the process.<br><br>Explore:- https://clival.com/blog/developing-formulations-for-phase-1-clinical-trials
E N D